Publications
3 shownRandomised trial of interferon α2b plus ribavirin for 48 weeks or for 24 weeks versus interferon α2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus
Only 15-20% of patients with chronic hepatitis C achieve a sustained virological response with interferon therapy. The aim of this study was to compare the efficacy and safety o...
Frequent Co-Authors
Researcher Info
- h-index
- 3
- Publications
- 3
- Citations
- 3,609
- Institution
- Service de la Santé Publique
External Links
Identifiers
- ORCID
- 0000-0002-2050-640X
Impact Metrics
h-index
3
h-index: Number of publications with at least h citations each.